Document is current
Any future updates will be listed below
-
Authors
Román Alonso, Macarena https://orcid.org/0000-0001-8128-9528
Grinyó-Escuer, Ariadna https://orcid.org/0000-0003-0185-2734
Duro-Sánchez, Santiago https://orcid.org/0000-0002-3829-7562
Rius-Ruiz, Irene
Bort-Brusca, Marta
Escorihuela, Marta
Maqueda-Marcos, Susana
Pérez-Ramos, Sandra https://orcid.org/0000-0002-3612-4027
Gago, Judit https://orcid.org/0009-0007-2317-1629
Nogales, Vanesa
Espinosa-Bravo, Martín https://orcid.org/0000-0002-4293-3875
Peg, Vicente
Escrivá-de-Romaní, Santiago
Foradada, Laia
Soucek, Laura https://orcid.org/0000-0002-4750-7971
Braña, Irene
Galvao, Vladimir
Martín-Lluesma, Silvia https://orcid.org/0000-0001-7491-1876
Moessner, Ekkehard
Klein, Christian https://orcid.org/0000-0001-7594-7280
Garralda, Elena https://orcid.org/0000-0002-4412-7842
Saura, Cristina https://orcid.org/0000-0001-8296-5065
Arribas, Joaquín https://orcid.org/0000-0002-0504-0664
- License Information
-
More Information
Article History
Received: 4 December 2023
Accepted: 8 October 2024
First Online: 18 November 2024
Competing interests
: J.A. has received research funds from Roche, Byondis, Menarini and Molecular Partners and consultancy honoraria from Menarini, Mnemo and ARKIN. J.A. is an inventor of patent applications EP22382294, EP20382457, EP16191933.7, EP0930183.5 and P200801652. M.R.A., I.R.R., C.K., E.M., are inventors of patent application EP20382457. M.R.A., S.D., A.G.E., I.R.R., V.N. are inventors of patent application EP22382294. C.K. declares employment, patents and stock ownership with Roche. E.M. declares employment with Roche. E.G. reports: research agreements with Novartis, Roche, Thermo Fisher, AstraZeneca, Taiho, BeiGene, Janssen; consultant/advisor at Roche, Ellipses Pharma, Boehringer Ingelheim, Janssen Global Services, Seattle Genetics, Thermo Fisher, MabDiscovery, Anaveon, F-Star Therapeutics, Hengrui, Sanofi, Incyte; and payment or honoraria for speakers’ bureaus from Merck Sharp & Dohme, Roche, Thermo Fisher, Lilly, Novartis, SeaGen. The remaining authors declare no competing interests.
